Matches in Wikidata for { <http://www.wikidata.org/entity/Q91732567> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91732567 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91732567 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91732567 description "scientific article published on 08 April 2020" @default.
- Q91732567 description "wetenschappelijk artikel" @default.
- Q91732567 description "наукова стаття, опублікована 8 квітня 2020" @default.
- Q91732567 name "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 name "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 type Item @default.
- Q91732567 label "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 label "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 prefLabel "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 prefLabel "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 P1433 Q91732567-F53151E9-90C5-47F8-A5AA-14F53A3545D3 @default.
- Q91732567 P1476 Q91732567-7B5D2765-36C4-4DF2-B7B2-7806657EA0B1 @default.
- Q91732567 P2093 Q91732567-006BDA56-78E2-4801-AD5B-A7F5DAE381DE @default.
- Q91732567 P2093 Q91732567-00E399BD-462D-4820-8D4B-79D99D71F67B @default.
- Q91732567 P2093 Q91732567-1757E489-FAE2-4E4A-8247-F3C5A505A5D3 @default.
- Q91732567 P2093 Q91732567-1F1A501F-D444-41A6-A832-413219A85D29 @default.
- Q91732567 P2093 Q91732567-26908ED5-D44E-40E3-9EDC-14850DD81FBA @default.
- Q91732567 P2093 Q91732567-2FCD293E-2FD4-4FFF-B753-EE1C08B9D6F5 @default.
- Q91732567 P2093 Q91732567-58C81866-4B5C-4D56-908D-0D4813131ECD @default.
- Q91732567 P2093 Q91732567-60794D0D-7EC3-47F7-95B7-B1C9E4D7578C @default.
- Q91732567 P2093 Q91732567-F66C7BA1-1C51-4A04-A3F4-4DA811FF376D @default.
- Q91732567 P31 Q91732567-9BAEAF7A-0FD7-44CC-B092-C04D6C339409 @default.
- Q91732567 P356 Q91732567-BB4906FA-8FF3-46FF-8039-500B4FE6ABCD @default.
- Q91732567 P577 Q91732567-198A5E8F-8986-4A31-9078-46A636C9F575 @default.
- Q91732567 P698 Q91732567-CE065491-C83D-4BC1-B7B6-1FF504438E98 @default.
- Q91732567 P356 A-1121-7593 @default.
- Q91732567 P698 32268436 @default.
- Q91732567 P1433 Q15754194 @default.
- Q91732567 P1476 "[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]" @default.
- Q91732567 P2093 "Axel S Merseburger" @default.
- Q91732567 P2093 "Christoph Rüssel" @default.
- Q91732567 P2093 "Hanjo Belz" @default.
- Q91732567 P2093 "Katrin Kruetzfeldt" @default.
- Q91732567 P2093 "Martin Bögemann" @default.
- Q91732567 P2093 "Nguyen Tran" @default.
- Q91732567 P2093 "Philipp Spiegelhalder" @default.
- Q91732567 P2093 "Susan Feyerabend" @default.
- Q91732567 P2093 "Werner Baurecht" @default.
- Q91732567 P31 Q13442814 @default.
- Q91732567 P356 "10.1055/A-1121-7593" @default.
- Q91732567 P577 "2020-04-08T00:00:00Z" @default.
- Q91732567 P698 "32268436" @default.